Approvals (Drugs@FDA)

GWYN LO

VIATRIS SPECIALTY · ETHINYL ESTRADIOL, NORELGESTROMIN

NDA219990Drug (NDA)Prescription
Open FDA's page for this record
Application number
NDA219990
Sponsor name
VIATRIS SPECIALTY
Submissions
  1. Submission type
    ORIG
    Submission number
    1
    Submission status
    AP
    Submission status date
    20260728
    Review priority
    STANDARD
    Submission class code
    TYPE 5
    Submission class code description
    Type 5 - New Formulation or New Manufacturer
    Application docs
    1. ID
      86759
      Url
      https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2026/219990Orig1s000ltr.pdf
      Date
      20260730
      Type
      Letter
Products
  1. Product number
    001
    Reference drug
    Yes
    Brand name
    GWYN LO
    Reference standard
    Yes
    Dosage form
    SYSTEM
    Route
    TRANSDERMAL
    Marketing status
    Prescription
    Active ingredients
    1. Name
      ETHINYL ESTRADIOL
      Strength
      0.02MG/24HR
    2. Name
      NORELGESTROMIN
      Strength
      0.22MG/24HR
Harmonized identifiers (openFDA)
Application number
NDA219990
Brand name
GWYN LO
Generic name
NORELGESTROMIN AND ETHINYL ESTRADIOL
Manufacturer name
Viatris Specialty LLC
Product NDC
49502-627
Product type
HUMAN PRESCRIPTION DRUG
Route
TRANSDERMAL
Substance name
NORELGESTROMIN, ETHINYL ESTRADIOL
RxCUI
2749430, 2749437
SPL ID
e92741f4-87fe-429f-b5b5-c558ed5f4fa9
SPL set ID
e92741f4-87fe-429f-b5b5-c558ed5f4fa9
Package NDC
49502-627-61, 49502-627-62, 49502-627-65, 49502-627-63, 49502-627-64
Nui
M0447349, N0000175602, N0000175825, N0000000100
Pharm class cs
Progesterone Congeners [CS]
Pharm class epc
Progestin [EPC], Estrogen [EPC]
Pharm class moa
Estrogen Receptor Agonists [MoA]
UNII
R0TAY3X631, 423D2T571U
Wholesale access for licensed clinicians.

Free to join: your NPI is checked against the federal registry at signup, then wholesale pricing and the professional shelves open.

Data from openFDA, FDA's public API. FDA says not to rely on it to make decisions about medical care and to treat every result as unvalidated; confirm against FDA's own record and the product labeling. Not medical or legal advice.